FDA grants Precigen platform technology designation for AdenoVerse

Go back to FDA grants Precigen platform technology designation for AdenoVerse
(NASDAQ: PGEN) Delayed: 6.60 -0.23 (3.37%)
Previous Close $6.83    52 Week High $ 
Open $6.79    52 Week Low $ 
Day High $6.92    P/E N/A 
Day Low $6.57    EPS $ 
Volume 5,969,299